Huge congrats to Drs. @EHeath4100 & @EAntonarakis on the new Mayo/UMN #ProstateCancer SPORE grant from @NCIDCTD! ๐ A well-deserved recognition of your leadership & a major step forward for mCRPC/APMR precision Rx research Link๐https://t.co/vMSQrzn6Jt @PCFnews@urotoday
๐ https://t.co/eLlsqoChBa congratulations @SyedAAhmad5 Wayne State Surgery, patients and trainees are so lucky to get such an amazing and empathic leader!
My Expert Commentary for @ASCO Daily News is out now: Multicancer Early Detection Test Clears Its First FDA Hurdle. It covers what the September 23 @FDA advisory committee votes on @GrailBio's Galleri test change for oncologists, and the three patient conversations to prepare for. See below!
Here we are again, less than 4 weeks to #ESMO26 - if feels like this year is flying! @myESMO
Had a chance to go through the #GI program and LBA titles just released - abstracts to be released on October 19th ๐
โก๏ธlots to watch for - especially busy in the Upper GI space.
๐my top abstracts picks below - I'm still old school so without the benefit of ChatGPT...pls let me know what I missed!
See you in #Madrid ๐
Grateful to be part of this incredible FDA team with such extraordinary expertise. Daraxonrasib was approved 6.5 months ahead of the original goal date.
@NCCN please rapidly update the #pancreaticcancer guidelines.
Insurance company AI denying patients Daraxonrasib and recommending I try gem/erlotinib first. Probably because it remains on guidelines for a 2 week survival advantage! I hope the guidelines will consider removing
Terribly awkward speaking picture but incredibly wonderful day spent at Vandy! Great science and truly such a great group of colleagues and friends. Looking forward to all the great collaborations. Thanks again for inviting me